NCT02371551

Brief Summary

The primary concern in complex renal cysts (CRC) with malignant potential is the accurate diagnosis and characterization. Patients with CRC have to undergo frequent imaging surveillance (every 6-12 Mo), in which the progression suggests a neoplastic process. The gold standard for establishing diagnosis and necessity for surgical intervention (i.e. partial nephrectomy) is conventional computer tomography (CT) imaging. Its main drawback is the radiation dose to the body and intravenous contrast media administration, which has a risk of nephrotoxicity. Magnetic resonance imaging (MRI) with special functional sequences (fMRI) and contrast-enhanced ultrasonography (CEUS) allow measuring tissue blood flow and perfusion characteristics without ionizing radiation or nephrotoxic contrast media. To compare the diagnostic accuracy, sensitivity and specificity of CEUS/functional MRI versus the gold standard CT, 60 patients with CRC will be evaluated using all these 3 modalities. The main hypothesis is that fMRI and CEUS have equal accuracy with CT regarding diagnosis and classification of CRC lesions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 19, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 19, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 25, 2015

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
Last Updated

August 28, 2019

Status Verified

August 1, 2019

Enrollment Period

3.2 years

First QC Date

February 19, 2015

Last Update Submit

August 27, 2019

Conditions

Keywords

Diffusion Magnetic Resonance ImagingMedical SonographyComputed Tomography, X-Ray

Outcome Measures

Primary Outcomes (1)

  • CRC classification according to CT-finding based on Bosniak criteria or until surgical intervention

    1 year

Secondary Outcomes (2)

  • Diagnostic accuracy of CEUS and fMRI based on the progression of CRC according to CT-finding and Bosniak classification throughout visit 1-2

    1 year

  • Diagnostic accuracy of CEUS and fMRI based on surgical extraction and histopathological evaluation of the resected mass

    1 year

Study Arms (1)

1

All patients

Other: Blood/urine samplingOther: Conventional routine CT examinationOther: Contrast-enhanced renal ultrasonography (CEUS)Other: Functional MRI

Interventions

Routine chemistry profile

1

Standard diagnostic examination

1

Study-specific diagnostic examination

1

Study-specific diagnostic examination

1

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who were referred to the outpatient clinic of the Department of Nephrology or to the Department of Urology, Bern University Hospital for the clarification of a complex renal cyst/lesion and already underwent or will undergo a standard CT examination or patient who where accidentally diagnosed with a complicated renal cyst/lesion from the Department of Nephrology, Urology or Radiology (with CT imaging)

You may qualify if:

  • Age \> 18 years old
  • Written informed consent
  • A complicated renal cyst (Bosniak category \> II cyst or hemorrhagic cyst) or lesion \> 1 cm im max. transverse diameter who will undergo standard renal CT imaging
  • Stable renal function (GFR\> 30 ml/min/1.73 m2)

You may not qualify if:

  • Pregnancy
  • History of allergic reaction to contrast agents
  • Refusal to adhere to follow-up
  • Recent pyelonephritis
  • Acute kidney injury (AKI stage ≥ 1)
  • Other individuals especially in need of protection (according to the Swiss Academy of Medical Sciences)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dep. of Nephrology, Hypertension and Clinical Pharmacology, Bern University Hospital

Bern, CH-3010, Switzerland

Location

Related Publications (5)

  • Bosniak MA. Diagnosis and management of patients with complicated cystic lesions of the kidney. AJR Am J Roentgenol. 1997 Sep;169(3):819-21. doi: 10.2214/ajr.169.3.9275903. No abstract available.

    PMID: 9275903BACKGROUND
  • Curry NS, Cochran ST, Bissada NK. Cystic renal masses: accurate Bosniak classification requires adequate renal CT. AJR Am J Roentgenol. 2000 Aug;175(2):339-42. doi: 10.2214/ajr.175.2.1750339.

    PMID: 10915671BACKGROUND
  • Balci NC, Semelka RC, Patt RH, Dubois D, Freeman JA, Gomez-Caminero A, Woosley JT. Complex renal cysts: findings on MR imaging. AJR Am J Roentgenol. 1999 Jun;172(6):1495-500. doi: 10.2214/ajr.172.6.10350279.

    PMID: 10350279BACKGROUND
  • Nicolau C, Bunesch L, Sebastia C. Renal complex cysts in adults: contrast-enhanced ultrasound. Abdom Imaging. 2011 Dec;36(6):742-52. doi: 10.1007/s00261-011-9727-8.

    PMID: 21461960BACKGROUND
  • Schneider AG, Hofmann L, Wuerzner G, Glatz N, Maillard M, Meuwly JY, Eggimann P, Burnier M, Vogt B. Renal perfusion evaluation with contrast-enhanced ultrasonography. Nephrol Dial Transplant. 2012 Feb;27(2):674-81. doi: 10.1093/ndt/gfr345. Epub 2011 Jun 20.

    PMID: 21690200BACKGROUND

MeSH Terms

Conditions

Kidney Diseases, CysticKidney Neoplasms

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Spyridon Arampatzis, MD

    Dep. of Nephrology, Hypertension and Clinical Pharmacology, Bern University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2015

First Posted

February 25, 2015

Study Start

August 19, 2014

Primary Completion

October 20, 2017

Study Completion

June 30, 2018

Last Updated

August 28, 2019

Record last verified: 2019-08

Locations